-8%

est. 2Y upside i

Series C

Olipop is a healthier alternative to traditional sodas by plant-based ingredients to support digestive health while emulating the flavors of classic sodas​​. The beverage contains prebiotics, fiber, and botanical extracts from eight different sources, boasting a low sugar and calorie content with various soda-style flavors like root beer, cola, and lemon lime​.

Rank

#3025

Sector

Beverage

Est. Liquidity

~3Y

Data Quality

Data: High

Olipop presents a moderate upside opportunity for a job seeker, driven by its impressive 100% YoY revenue growth to $400M and current profitability in the rapidly expanding functional beverage market.

Last updated: March 10, 2026

Bull (25%)+150%

Olipop successfully navigates the class-action lawsuit, continues its aggressive growth to over $800M in revenue by 2028, and is acquired by a major beverage conglomerate (e.g., Coca-Cola or Keurig Dr Pepper) at a premium valuation of $4.75B, recognizing its market leadership in functional beverages.

Base (30%)+50%

Olipop maintains strong growth, reaching approximately $600M in revenue by 2028, but faces increased competitive pressure from incumbents and a moderate impact from the lawsuit. It achieves a valuation of $2.85B through a strategic investment or a modest acquisition, reflecting its established brand and distribution.

Bear (45%)-60%

The class-action lawsuit significantly damages Olipop's brand reputation and sales, while dominant incumbents like PepsiCo and Coca-Cola aggressively capture market share with their own functional beverage lines. Growth stalls, leading to a down round or an acquisition at a distressed valuation of $0.76B, severely impacting common stock value.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

13%

Investors hold $243M in liquidation preferences ahead of common stock, representing 12.79% of the current valuation.

Dilution Risk

moderate

As a Series C+ company, future growth equity rounds or an IPO/acquisition could lead to further dilution for common shareholders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Olipop equity.

View all 4 open roles at Olipop →

Last updated: March 8, 2026

Questions to Ask at the Interview

Strategic questions based on Olipop's data — designed to show you've done your homework.

  • 1

    “How is Olipop strategically addressing the class-action lawsuit regarding its gut health claims, and what measures are being taken to reinforce the scientific substantiation of your product benefits?”

  • 2

    “With major incumbents like PepsiCo and Coca-Cola actively expanding into the functional beverage market, what is Olipop's long-term strategy to maintain its market leadership and competitive moat?”

  • 3

    “Given the company's Series C+ funding stage and the strong M&A signals, what is the anticipated timeline and preferred exit strategy for Olipop, and how might that impact employee equity?”

Community

Valuation Sentiment

Our model estimates -8% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.